• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗着丝粒抗体阳性患者的临床表型并非由CENP - B抗原的表位识别所决定。

The clinical expression in anticentromere antibody-positive patients is not specified by the epitope recognition of CENP-B antigen.

作者信息

Muro Y, Sugimoto K, Himeno M, Ohashi M

机构信息

Department of Dermatology, Nagoya University School of Medicine, Japan.

出版信息

J Dermatol. 1992 Oct;19(10):584-91. doi: 10.1111/j.1346-8138.1992.tb03734.x.

DOI:10.1111/j.1346-8138.1992.tb03734.x
PMID:1283396
Abstract

Centromere protein B (CENP-B), which is an alphoid DNA binding protein, is the target antigen in autoimmune disease patients (often with scleroderma). From our previous analysis of the reactivity of anticentromere sera, four independent epitopes were identified on recombinant CENP-B. The anticentromere sera displayed heterogeneity in their patterns of reactivity to the four epitopes. We have investigated to what extent this heterogeneity of the target autoepitope on CENP-B accounts for the clinical diversity of anticentromere antibody (ACA)-positive patients. A major autoepitope, epitope I, was recognized by all 40 ACA-positive sera; however, the other three epitopes were recognized differently from case to case. We could not find any significant correlation between the reactivity to CENP-B autoepitopes and the clinical presentation of ACA-positive patients. There was considerable clinical diversity, even among the nine patients showing specificity for the single major autoepitope. In conclusion, we found that, although ACA-positive patients were both clinically and immunologically heterogeneous, in most respects the clinical expression appeared to be independent of the reactivity to the CENP-B autoepitope, a finding which suggests that identification of the target epitope of CENP-B is unlikely to assist in the clinical classification of the disease in ACA-positive patients. The identification of multiple B cell epitopes on CENP-B is consistent with the concept that the self-antigen drives the antibody response. However, factors other than CENP-B autoepitope specificity must determine the clinical expression of ACA responses.

摘要

着丝粒蛋白B(CENP - B)是一种α卫星DNA结合蛋白,是自身免疫性疾病患者(常患硬皮病)体内的靶抗原。根据我们之前对抗着丝粒血清反应性的分析,在重组CENP - B上鉴定出了四个独立的表位。抗着丝粒血清对这四个表位的反应模式存在异质性。我们研究了CENP - B上靶自身表位的这种异质性在多大程度上导致了抗着丝粒抗体(ACA)阳性患者的临床多样性。一个主要的自身表位,即表位I,被所有40份ACA阳性血清识别;然而,其他三个表位的识别情况则因病例而异。我们未发现对CENP - B自身表位的反应性与ACA阳性患者临床表现之间存在任何显著相关性。即使在对单一主要自身表位具有特异性的九名患者中,临床多样性也相当大。总之,我们发现,尽管ACA阳性患者在临床和免疫学上均具有异质性,但在大多数方面,临床表型似乎与对CENP - B自身表位的反应性无关,这一发现表明,鉴定CENP - B的靶表位不太可能有助于对ACA阳性患者进行疾病的临床分类。在CENP - B上鉴定出多个B细胞表位与自身抗原驱动抗体反应这一概念相符。然而,除CENP - B自身表位特异性之外的因素必定决定了ACA反应的临床表型。

相似文献

1
The clinical expression in anticentromere antibody-positive patients is not specified by the epitope recognition of CENP-B antigen.抗着丝粒抗体阳性患者的临床表型并非由CENP - B抗原的表位识别所决定。
J Dermatol. 1992 Oct;19(10):584-91. doi: 10.1111/j.1346-8138.1992.tb03734.x.
2
Anticentromere antibody-positive primary Sjögren's syndrome: Epitope analysis of a subset of anticentromere antibody-positive patients.抗着丝点抗体阳性的原发性干燥综合征:抗着丝点抗体阳性患者亚组的表位分析
Mod Rheumatol. 2017 Jan;27(1):115-121. doi: 10.1080/14397595.2016.1176327. Epub 2016 May 10.
3
Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.无雷诺病或系统性硬化症患者的抗着丝点自身抗体。
Clin Immunol. 1999 Feb;90(2):182-9. doi: 10.1006/clim.1998.4643.
4
Anticentromere-protein-B--DNA complex activities in anticentromere antibody-positive patients.抗着丝点抗体阳性患者中抗着丝点蛋白B-DNA复合物的活性
Arch Dermatol Res. 1992;284(7):396-9. doi: 10.1007/BF00372069.
5
A charged segment mainly composed of basic amino acids forms an autoepitope of CENP-A.一个主要由碱性氨基酸组成的带电荷片段形成了着丝粒蛋白A的自身表位。
Clin Immunol Immunopathol. 1996 Jan;78(1):86-9. doi: 10.1006/clin.1996.0013.
6
[Clinical significance of anti-centromere antibody and anti-CENP-B antibody in sera of patients with primary biliary cirrhosis].[抗着丝点抗体和抗CENP - B抗体在原发性胆汁性肝硬化患者血清中的临床意义]
Rinsho Byori. 1996 Sep;44(9):877-82.
7
Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma).接触石英粉尘的铀矿工血清及可能发展为系统性硬化症(硬皮病)患者血清中的抗着丝粒蛋白B反应
J Rheumatol. 1995 Jul;22(7):1286-94.
8
High prevalence of antibodies to recombinant CENP-B in primary biliary cirrhosis: nuclear immunofluorescence patterns and ELISA reactivities.原发性胆汁性肝硬化中重组着丝粒蛋白B抗体的高流行率:核免疫荧光模式和酶联免疫吸附测定反应性
J Gastroenterol Hepatol. 1995 Jul-Aug;10(4):438-45. doi: 10.1111/j.1440-1746.1995.tb01597.x.
9
An antigenic determinant on human centromere protein B (CENP-B) available for production of human-specific anticentromere antibodies in mouse.人着丝粒蛋白B(CENP-B)上的一个抗原决定簇,可用于在小鼠体内产生人特异性抗着丝粒抗体。
Cell Struct Funct. 1992 Apr;17(2):129-38. doi: 10.1247/csf.17.129.
10
Analysis of anticentromere autoantibodies using cloned autoantigen CENP-B.使用克隆的自身抗原CENP-B分析抗着丝粒自身抗体。
Proc Natl Acad Sci U S A. 1987 Jul;84(14):4979-83. doi: 10.1073/pnas.84.14.4979.

引用本文的文献

1
Centromere Identity and the Regulation of Chromosome Segregation.着丝粒身份与染色体分离的调控
Front Cell Dev Biol. 2022 Jun 2;10:914249. doi: 10.3389/fcell.2022.914249. eCollection 2022.
2
Fine specificity mapping of autoantigens targeted by anti-centromere autoantibodies.抗着丝粒自身抗体靶向的自身抗原的精细特异性图谱分析。
J Autoimmun. 2006 Dec;27(4):272-80. doi: 10.1016/j.jaut.2006.10.001. Epub 2007 Jan 8.
3
Autoepitopes on autoantigen centromere protein-A (CENP-A) are restricted to the N-terminal region, which has no homology with histone H3.
自身抗原着丝粒蛋白A(CENP-A)上的自身表位局限于N端区域,该区域与组蛋白H3没有同源性。
Clin Exp Immunol. 2000 Apr;120(1):218-23. doi: 10.1046/j.1365-2249.2000.01189.x.
4
cDNA cloning of a novel autoantigen targeted by a minor subset of anti-centromere antibodies.一种新型自身抗原的cDNA克隆,该抗原是一小部分抗着丝粒抗体的靶向目标。
Clin Exp Immunol. 1998 Feb;111(2):372-6. doi: 10.1046/j.1365-2249.1998.00517.x.